Results 201 to 210 of about 173,176 (244)
Advanced extracellular vesicle immunotherapy
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang +6 more
wiley +1 more source
Different fatty acid patterns in serum in patients with various thyroid diseases. [PDF]
Lukasiewicz M +7 more
europepmc +1 more source
ABSTRACT Background Post‐stroke gastroparesis (GP) is a debilitating complication that severely impairs quality of life. Although abdominal acupuncture is widely used, robust evidence regarding its efficacy, particularly concerning the critical parameter of the needling depth, is still lacking.
Xiangcheng Wei +8 more
wiley +1 more source
Structural basis of product recognition by Mycobacterium tuberculosis fatty acid synthase. [PDF]
Samani EK +4 more
europepmc +1 more source
Interkingdom Interactions in the Gut: Ecological Mechanisms, Homeostasis, and Therapeutic Modulation
ABSTRACT The gut microbiota constitutes a highly complex and dynamic ecosystem that profoundly influences host physiology, metabolism, and immunity. This review provides an integrative overview of the mechanisms through which gut microorganisms—particularly bacteria and fungi—interact with host cells and with each other to maintain intestinal ...
Rui‐Qi Wei +5 more
wiley +1 more source
Diagnostic Value of miR-1225-5p in Acute Coronary Syndrome and its Mechanism in ox-LDL Induced Human Coronary Artery Endothelial Cells Injury. [PDF]
Ju H, Si P, Li S, Yang D.
europepmc +1 more source
Seed fatty acid composition and physical dormancy in fire-prone ecosystems. [PDF]
McInnes SJ, Tangney R, Ooi MKJ.
europepmc +1 more source
Screening and verification of drugs targeting myocardial ischemia-reperfusion injury. [PDF]
Liu Q, Tian Z, Mi S, Liang Z, Hang B.
europepmc +1 more source
What's New? The CDK4/6 inhibitor ribociclib in combination with an endocrine‐based therapy has demonstrated significant progression‐free and overall survival benefits in patients with advanced/metastatic HR+/HER2‐ breast cancer in the pivotal MONALEESA trials.
Peter A. Fasching +20 more
wiley +1 more source

